Phytosterolaemia: Diagnosis, characterization and therapeutical approaches

Annals of Medicine

Volumn 29, Issue 3, 1997, Pages 181-184

  Lütjohann, Dieter ^a   Von Bergmann, Klaus ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Bile acid excretion; Cholesterol synthesis; Plant sterols; Sitostanol; Sterol absorption; Sterol excretion

Indexed keywords

BILE ACID; CAMPESTEROL; CHOLESTEROL; PHYTOSTEROL; SITOSTANOL; SITOSTEROL;

BILIARY EXCRETION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CORONARY ARTERY ATHEROSCLEROSIS; DIET RESTRICTION; ILEUM BYPASS; INTESTINE ABSORPTION; PRIORITY JOURNAL; SHORT SURVEY; STORAGE DISEASE; XANTHOMA;

EID: 0030762693     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899708999333     Document Type: Short Survey

References (59)

1. Schönheimer R. Über die Bedeutung der Pflanzensterine für den tierischen Organismus. Hoppe Seyler Ztschr Phys Chem 1929; 180: 1-37.
2. Fedeli E, Jacini G. Lipid composition of vegetable oils. Adv Lipid Res 1971; 9: 335-82.
3. Weihrauch JL, Gardner JM. Sterol content of foods of plant origin. J Am Diet Assoc 1978; 73: 39-47.
4. Ling WH, Jones PJ. Dietary phytosterols: a review of metabolism, benefits and side effects. Life Sci 1995; 57: 195-206.
5. Subbiah MTR. Significance of dietary plant sterols in man and experimental animals. Mayo Clin Proc 1971; 46: 549-52.
6. Salen G, Ahrens EH Jr, Grundy SM. Metabolism of β-sitosterol in man. J Clin Invest 1970; 49: 952-67.
7. Kudchodkar BJ, Sodhi HS, Horlick L. Absorption of dietary cholesterol in man. Metabolism 1973; 22: 155-63.
8. Lütjohann D, Meese CO, Crouse JR III, von Bergmann K. Evaluation of deuterated cholesterol and deuterated sitostanol for measurement of cholesterol absorption in man. J Lipid Res 1993; 34: 1039-46.
9. Gould RG, Jones RJ, LeRoy GV, Wissler RW, Taylor CB. Absorbability of β-sitosterol in humans. Metabolism 1969; 18: 652-62.
10. Björkhem I, Muri-Boberg K. Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, Vol. 2, 7th edn. New York: McGraw-Hill, 1995: 2073-99.
11. Lütjohann D, Björkhem I, Beil UF, von Bergmann K. Sterol absorption and sterol balance in phytosterolemia evaluated by deuterium-labeled sterols: effect of sitostanol treatment. J Lipid Res 1995; 36: 1763-73.
12. Lütjohann D, Björkhem I, Ose L. Phytosterolemia in a Norwegian family: diagnosis and characterization of the first Scandinavian case. Scand J Clin Lab Invest 1996; 56: 229-40.
13. Heinemann T, Axtmann G, von Bergmann K. Comparison of intestinal absorption of cholesterol with different plant sterols in man. Eur J Clin Invest 1993; 23: 827-31.
14. Heinemann T, Kullak-Ublick GA, Pietruck B, von Bergmann K. Mechanism of action of plant sterols on inhibition of cholesterol absorption. Eur J Clin Pharmacol 1991; 40 (Suppl 1): 59-63.
15. Hassan AS, Rampone AJ. Intestinal absorption and lymphatic transport of cholesterol and β-sitostanol in the rat. J Lipid Res 1979; 20: 646-53.
16. Terry JG, McGill BL, Crouse JR III. Evaluation of the use of beta-sitostanol as a nonabsorbable marker for quantifying cholesterol absorption. J Lipid Res 1995; 36: 2267-71.
17. Czubayko F, Beumers B, Lammsfuss S, Lütjohann D, von Bergmann K. A simplified method for quantification of fecal excretion of neutral and acidic sterols for outpatient studies in humans. J Lipid Res 1991; 32: 1861-7.
18. Eneroth P, Hellström K, Ryhage R. Identification of two neutral metabolites of stigmasterol found in human feces. Steroids 1965; 6: 707-20.
19. Boberg KM, Einarsson K, Björkhem I. Apparent lack of conversion of sitosterol into C-24 bile acids in humans. J Lipid Res 1990; 31: 1083-8.
20. Hoving EB. Chromatographic methods in the analysis of cholesterol and related lipids. J Chromatogr B Biomed Appl 1995; 671: 341-62.
21. Miettinen TE, Kesäniemi YA, Gylling H, Järvinen H, Silvennoinen E, Miettinen TA. Noncholesterol sterols in bile and stones of patients with cholesterol and pigment stones. Hepatology 1996; 23: 274-80.
22. Dyer RG, Hetherington CS, Alberti K, Laker MF. Simultaneous measurement of phytosterols (campesterol and beta-sitosterol) and 7-ketocholesterol in human lipoproteins by capillary column gas chromatography. J Chromatogr B Biomed Appl 1995; 663: 1-7.
23. Tvrzicka E, Mares P, Pisarikova A, Novakovic J, Hrabak R Simplified gas chromatographic method for the simultaneous determination of phytosterols and cholesterol. J Chromatogr 1991; 563: 188-92.
24. Mellies M, Glueck CJ, Sweeney C, Fallat RW, Tsang RC, Ishikawa TT. Plasma and dietary phytosterols in children. Pediatrics 1976; 57: 60-7.
25. Clayton PT, Bowron A, Mills KA, Massoud A, Casteels M, Milla PJ. Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology 1993; 13; 105: 1806-13.
26. Bhattacharrya AK, Connor WE. β-sitosterolemia and xanthomatosis: a newly described lipid storage disease in two sisters. J Clin Invest 1974; 53: 1033-43.
27. Salen G, Kwiterovich PO Jr, Shefer S, et al. Increased plasma cholestanol and 5α-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis. J Lipid Res 1985; 26: 203-9.
28. Bhattacharyya AK, Connor WE, Lin DS. The origin of plant sterols in the skin surface lipids in humans: from diet to plasma to skin. J Invest Dermatol 1983; 80: 294-6.
29. Salen G, Horak I, Rothkopf M, et al. Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis. J Lipid Res 1985; 26: 1126-33.
30. Grahlke BK. Xanthomatose der Achillessehnen als Leitsymptome der Sitoterinämie. Dtsch Med Wochenschr 1991; 116: 335-8.
31. Shulman RS, Bhattacharrya AK, Connor WE, Fredrickson DS. β-sitosterolemia and xanthomatosis. N Engl J Med 1976; 294: 482-3.
32. Miettinen TA. Phytosterolemia, xanthomatosis and premature atherosclerotic arterial disease: a case with high plant sterol absorption, impaired sterol absorption and low cholesterol synthesis. Eur J Clin Invest 1980; 10: 27-35.
33. Salen G, Shore V, Tint GS, et al. Increased sitosterol absorption, decreased removal, and expanded body pools compensate for reduced cholesterol synthesis in sitosterolemia with xanthomatosis. J Lipid Res 1989; 30: 1319-30.
34. Gregg RE, Connor WE, Lin DS, Brewer HB Jr. Abnormal metabolism of shellfish sterols in a patient with sitosterolemia and xanthomatosis. J Clin Invest 1986; 77: 1864-72.
35. Low LL, Lin HJ, Lau KS, Kung AW, Yeung CY. Phytosterolemia and pseudohomozygous type II hypercholesterolemia in two Chinese patients. J Pediatr 1991; 118: 746-9.
36. Watts GF, Mitchell WD. Clinical and metabolic findings in a patient with phytosterolaemia. Ann Clin Biochem 1992; 29: 231-6.
37. Berger GM, Deppe WM, Marais AD, Biggs M. Phytosterolaemia in three unrelated South African families. Postgrad Med J 1994; 70: 631-7.
38. Parsons HG, Jamal R, Baylis B, Dias VC, Roncari D. A marked and sustained reduction in LDL sterols by diet and cholestyramine in β-sitosterelmia. Clin Invest Med 1995; 18: 389-400.
39. Hallböök T, Kristiansson B, Hildebrand H, Nordin G, Lütjohann D, Björkhem I. Phytosterolaemia: an unknown but serious disease (in Swedish). Läkartidningen 1996; 93: 4275-7.
40. Bhadra S, Subhia MT. Incorporation of liposomal phytosterols into human cells in culture: a potential in vitro model for investigating pathological effects of phytosterolemia. Biochem Med Metab Biol 1991; 46: 119-24.
41. Tabas I, Feinmark SJ, Beatini N. The reactivity of desmosterol and other shellfish and xanthomatosis-associated sterols in the macrophage sterol esterification reaction. J Clin Invest 1989; 84: 1713-21.
42. Bhattacharrya AK, Connor WE, Lin DS, McMurry MM, Shulman RS. Sluggish sitosterol turnover and hepatic failure to excrete sitosterol into bile cause expansion of body pool sitosterol in patients with sitosterolemia and xanthomatosis. Atherioscler Thromb 1991; 11: 1287-94.
43. Lin HJ, Wang C, Salen G, Lam KC, Chan TK. Sitosterol and cholesterol metabolism in a patient with coexisting phytosterolemia and cholestanolemia. Metabolism 1983; 32: 126-33.
44. Nguyen LB, Salen G, Shefer S, et al. Decreased cholesterol biosynthesis in sitosterolemia with xanthomatosis: diminished mononuclear leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and enzyme protein associated with increased low-density lipoprotein receptor function. Metabolism 1990; 39: 436-43.
45. Nguyen LB, Salen G, Shefer S, et al. Deficient ileal 3-hydroxy-3-methyl glutaryl coenzyme A reductase activity in sitosterolemia: sitosterol is not a feedback inhibitor of intestinal cholesterol biosynthesis. Metabolism 1994; 43: 855-9.
46. Shefer S, Salen G, Bullock J, et al. The effect of increased hepatic sitosterol on the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and cholesterol 7 alpha-hydroxylase in the rat and sitosterolemic homozygotes. Hepatology 1994; 200: 213-9.
47. Ngyuen LB, Shefer S, Salen G, et al. A molecular defect in hepatic cholesterol biosynthesis in sitosterolemia and xanthomatosis. J Clin Invest 1990; 86: 923-31.
48. Khachadurian AK, Clancy KF. Familial phytosterolemia (β-sitosterolemia): report of five cases and studies in cultured fibroblasts. Clin Res 1978; 26: 329A.
49. Beil FU, Vega GL, Ma PA, Garg A, Grundy SM. Lipoprotein kinetics in β-sitosterolemia. Arteriosclerosis 1988; 8: 587a.
50. Boberg KM, Akerlund JE, Björkhem I. Effect of sitosterol on the rate limiting enzymes in cholesterol synthesis and degradation. Lipids 1989; 24: 9-12.
51. Shefer S, Hauser S, Lapar V, Mosbach EH. Regulatory effects of sterols and bile acids on hepatic 3-hydroxy-3-methyl-glutaryl CoA reductase and cholesterol 7α-hydroxylase in the rat. J Lipid Res 1973; 13: 573-80.
52. Shefer S, Salen G, Nguyen L, et al. Competitive inhibition of bile acid biosynthesis by endogenous cholestanol and sitosterol in sitosterolemia with xanthomatosis. Effect on cholesterol 7α-hydroxylase. J Clin Invest 1988; 82: 1833-9.
53. Bhattacharrya AK, Connor WE. Familial diseases with storage of sterols other than cholesterol: cerebrotendinous xanthomatosis, and β-sitosterolemia and xanthomatosis. In: Stanbury B, Wyngaarden, Fredrickson DS, eds. The Metabolic Basis of Inherited Disease, 4th edn. New York: McGraw-Hill, 1978: 656-87.
54. Kuksis I, Myher JJ, Marai L, Little JA, McArthur RG, Roncari DAK. Fatty acid composition of individual plasma steryl esters in phytosterolemia and xanthomatosis. Lipids 1986; 21: 371-7.
55. Nguyen LB, Cobb M, Shefer S, Salen G, Ness GC, Tint GS. Regulation of cholesterol biosynthesis in sitosterolemia: effects of lovastatin, cholestyramine, and dietary sterol restriction. J Lipid Res 1991; 32: 1941-8.
56. Belamarich PF, Deckelbaum RJ, Starc TJ, Dobrin BE, Tint GS, Salen G. Response to diet and cholestyramine in a patient with sitosterolemia. Pediatrics 1990; 86: 977-81.
57. Cobb MM, Salen G, Tint GS, Greenspan J, Nguyen LB. Sitosterolemia: opposing effects of cholestyramine and lovastatin on plasma sterol levels in a homozygous girl and her heterozygous father. Metabolism 1996; 45: 673-9.
58. Becker M, Staab D, von Bergmann K. Treatment of severe familial hypercholesterolemia in childhood with sitosterol and sitostanol. J Pediatr 1993; 122: 292-6.
59. Heinemann T, Leiss O, von Bergmann K. Effect of low dose sitostanol on serum cholesterol in patients with hypercholesterolemia. Atherosclerosis 1986; 61: 219-23.